v3 Template
C
Caeregen Therapeutics
Biotechnology/Healthcare
Founded
--
Employees
--
Total Funding
$1.4M
Funding Rounds
1
Last Funding
2023-07-17
About Caeregen Therapeutics
RetiNova Therapeutics is focused on developing the first regenerative therapy for retinal ischemic disease.
Products & Services
Regenerative Therapy:A therapy aimed at treating retinal ischemic disease.
Specialties
Regenerative Therapy
Retinal Ischemic Disease Treatment
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Phase 2 SBIR Grant T: - FT: Phase 2 SBIR Grant |
A: 1400000 MR: - FA: 1.4 million FAN: 1400000 |
D: 2023-07-17 FD: 2023-07-17 |
2 investors |
Phase 2 SBIR Grant
Latest
2023-07-17
$1.4M
2 investors (Pro only)
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
No team data available
Team information is not yet available for this company
Recent News
Caeregen Therapeutics Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- caeregen.com
- Industries
- Biotechnology/Healthcare
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro